Schlagworte:
Publikationen von Federico Spagnolo sortiert nach Zeitschrift und Typ
Frontiers in Neuroimaging
| , , , , , , , und , Down-sampling in diffusion MRI: a bundle-specific DTI and NODDI study (2024), in: Frontiers in Neuroimaging, 3 |
[DOI] [URL] |
Multiple Sclerosis Journal
| , , , , , , , , , , , , und , A multi-modal deep learning network for the classification of paramagnetic rim and remyelinated lesions in multiple sclerosis (2026), in: Multiple Sclerosis Journal |
Nature Scientific Reports
| , , , , , , , und , Instance-level quantitative saliency in multiple sclerosis lesion segmentation (2026), in: Nature Scientific Reports |
[DOI] [URL] |
NeuroImage: Clinical
, , , , , , und , How far MS lesion detection and segmentation are integrated into the clinical workflow? A systematic review (2023), in: NeuroImage: Clinical, 39(103491)
|
[DOI] [URL] |
Publikationen vom Typ Inproceedings
2025
| , , , , , , , , , , und , Deep-PRL: a deep learning network for the identification of paramagnetic rim lesions in multiple sclerosis, in: ISMRM 2025, 2025 |
|
| , , , , , , und , Exploiting XAI maps to improve MS lesion segmentation and detection in MRI, in: Workshop on Interpretability of Machine Intelligence in Medical Image Computing at MICCAI, 2025 |
[DOI] |
2024
| , , , , , , , , , , , und , Explainability in automatic Paramagnetic Rim Lesion classification, in: 40th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis (ECTRIMS), 2024 |
|
| , , , , , , , und , Instance-level explanations in multiple sclerosis lesion segmentation: a novel localized saliency map, in: ISMRM 2024, 2024 |
[URL] |
2023
| , , , , , , , und , FLAIR vs MPRAGE contribution to white matter lesion automatic segmentation in MS using localized saliency maps, in: Bern Interpretable AI Symposium (BIAS), 2023 |
|
| , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , und , Identification of paramagnetic rim lesions using conventional MRI - a deep learning approach, in: 39th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis (ECTRIMS), 2023 |
|